Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Babjuk

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
European Urology Oncology|May 11, 2020
Unanswered Questions for Bladder Tumours Unresponsive to Bacillus Calmette-GuérinMarko Babjuk
European Urology|July 16, 2016
Trends in Bladder Cancer Incidence and Mortality: Success or Disappointment?Marko Babjuk
European Urology|October 23, 2009
What is the optimal treatment strategy for T1 bladder tumors?Marko Babjuk
European Urology|February 3, 2020
Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments?Marko Babjuk
European Urology|December 3, 2022
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness StudyMarko Babjuk
European Urology|December 22, 2007
Editorial comment on: photodynamic diagnosis in urology: state-of-the-artMarko Babjuk
European Urology|May 1, 2007
Editorial comment on: Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urineMarko Babjuk
European Urology|April 30, 2010
Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectivesMarko Babjuk
World Journal of Urology|March 6, 2019
En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?Marko Babjuk
European Urology|March 14, 2015
Words of wisdom. Re: The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-GuerinMarko Babjuk
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
European Urology Oncology|May 11, 2020
Unanswered Questions for Bladder Tumours Unresponsive to Bacillus Calmette-GuérinMarko Babjuk
European Urology|July 16, 2016
Trends in Bladder Cancer Incidence and Mortality: Success or Disappointment?Marko Babjuk
European Urology|October 23, 2009
What is the optimal treatment strategy for T1 bladder tumors?Marko Babjuk
European Urology|February 3, 2020
Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments?Marko Babjuk
European Urology|December 3, 2022
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness StudyMarko Babjuk
European Urology|December 22, 2007
Editorial comment on: photodynamic diagnosis in urology: state-of-the-artMarko Babjuk
European Urology|May 1, 2007
Editorial comment on: Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urineMarko Babjuk
European Urology|April 30, 2010
Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectivesMarko Babjuk
World Journal of Urology|March 6, 2019
En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?Marko Babjuk
European Urology|March 14, 2015
Words of wisdom. Re: The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-GuerinMarko Babjuk
Pageof 12